Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300139
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,537
Award facts
- Contract value 100% obligated
- $4,536.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the procurement of drugs and biologicals. The contract was awarded on May 16, 2014 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract has a ceiling value of $4,536.72 and a completion date of December 31, 2014. The contract is a BPA Call with a firm fixed price pricing type, and it was awarded by the Office of the Director, a civilian federal agency.
Roche Diagnostics Corporation holds multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several VA-specific IDCs with ceiling values ranging from $208,000 to $3.1 million. These contract vehicles enable federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms, supporting healthcare delivery across military, veterans, and civilian healthcare systems.
The contract award does not have a set-aside designation, indicating that Roche Diagnostics Corporation competed openly in the federal marketplace.
Quick answers
Who was awarded contract HHSN26300139?
HHSN26300139 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on May 16, 2014.
How much is contract HHSN26300139 worth?
The government has obligated $4,537 on HHSN26300139.
Is contract HHSN26300139 an order under another contract?
Yes. HHSN26300139 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300139 competed?
The extent of competition for HHSN26300139 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award